HomePTIXW • NASDAQ
add
Protagenic Therapeutics
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.67M | 45.78% |
Net income | -1.61M | -32.82% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.65M | -44.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 924.60K | -84.70% |
Total assets | 1.47M | -78.80% |
Total liabilities | 674.56K | -55.19% |
Total equity | 792.52K | — |
Shares outstanding | 4.47M | — |
Price to book | 0.05 | — |
Return on assets | -206.07% | — |
Return on capital | -285.02% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.61M | -32.82% |
Cash from operations | -1.55M | -1.31% |
Cash from investing | 1.60M | -0.75% |
Cash from financing | 44.53K | — |
Net change in cash | 92.82K | 14.67% |
Free cash flow | -935.92K | 20.35% |
About
Founded
1994
Website
Employees
2